CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 255 filers reported holding CANTEL MEDICAL CORP in Q1 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $460,000 | +1.3% | 5,758 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $454,000 | +74.6% | 5,758 | -2.6% | 0.00% | +100.0% |
Q3 2020 | $260,000 | -0.4% | 5,912 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $261,000 | +23.1% | 5,912 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $212,000 | -48.8% | 5,912 | +1.1% | 0.00% | -50.0% |
Q4 2019 | $414,000 | -5.3% | 5,845 | 0.0% | 0.00% | -33.3% |
Q3 2019 | $437,000 | -7.2% | 5,845 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $471,000 | +7.5% | 5,845 | -10.7% | 0.00% | 0.0% |
Q1 2019 | $438,000 | -94.1% | 6,546 | -93.4% | 0.00% | -94.3% |
Q4 2018 | $7,388,000 | -46.7% | 99,232 | -34.1% | 0.05% | -36.9% |
Q3 2018 | $13,859,000 | +2.1% | 150,547 | +9.0% | 0.08% | -4.5% |
Q2 2018 | $13,579,000 | -57.2% | 138,054 | -51.6% | 0.09% | -58.3% |
Q1 2018 | $31,758,000 | -7.4% | 285,054 | -14.5% | 0.21% | -3.7% |
Q4 2017 | $34,298,000 | +9.2% | 333,412 | 0.0% | 0.22% | -3.1% |
Q3 2017 | $31,397,000 | +20.8% | 333,412 | -0.1% | 0.23% | +18.3% |
Q2 2017 | $26,001,000 | -2.7% | 333,725 | 0.0% | 0.19% | -5.9% |
Q1 2017 | $26,731,000 | -3.7% | 333,725 | -5.3% | 0.20% | -8.6% |
Q4 2016 | $27,748,000 | -9.8% | 352,353 | -10.7% | 0.22% | -11.2% |
Q3 2016 | $30,775,000 | +13.3% | 394,648 | -0.2% | 0.25% | +11.1% |
Q2 2016 | $27,169,000 | -3.7% | 395,302 | 0.0% | 0.22% | -3.0% |
Q1 2016 | $28,209,000 | +14.3% | 395,302 | -0.5% | 0.23% | +11.5% |
Q4 2015 | $24,681,000 | +9.6% | 397,181 | 0.0% | 0.21% | +4.5% |
Q3 2015 | $22,520,000 | +5.6% | 397,181 | 0.0% | 0.20% | +14.4% |
Q2 2015 | $21,317,000 | +13.0% | 397,181 | 0.0% | 0.17% | +12.3% |
Q1 2015 | $18,866,000 | +9.8% | 397,181 | 0.0% | 0.16% | +9.2% |
Q4 2014 | $17,182,000 | +24.3% | 397,181 | -1.3% | 0.14% | +19.3% |
Q3 2014 | $13,828,000 | -6.1% | 402,220 | 0.0% | 0.12% | -4.0% |
Q2 2014 | $14,729,000 | +8.3% | 402,220 | -0.2% | 0.12% | +6.9% |
Q1 2014 | $13,596,000 | -0.6% | 403,208 | -0.0% | 0.12% | -1.7% |
Q4 2013 | $13,674,000 | +6.5% | 403,246 | 0.0% | 0.12% | -0.8% |
Q3 2013 | $12,843,000 | +41.1% | 403,246 | +50.0% | 0.12% | +38.4% |
Q2 2013 | $9,105,000 | – | 268,831 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DIKER MANAGEMENT LLC | 1,084,317 | $85,509,000 | 43.23% |
Leonard Green & Partners, L.P. | 2,100,000 | $165,606,000 | 2.29% |
Champlain Investment Partners, LLC | 3,952,620 | $311,704,000 | 1.79% |
Brown Capital Management | 2,454,770 | $193,583,000 | 1.34% |
Aurora Investment Counsel | 19,502 | $1,538,000 | 1.24% |
Conestoga Capital Advisors, LLC | 797,481 | $62,889,000 | 1.00% |
EMERALD ADVISERS, LLC | 292,554 | $23,071,000 | 0.77% |
FRED ALGER MANAGEMENT, LLC | 3,470,340 | $273,671,000 | 0.71% |
GENEVA CAPITAL MANAGEMENT LLC | 510,171 | $40,232,000 | 0.68% |
WASHINGTON CAPITAL MANAGEMENT, INC | 7,650 | $603,000 | 0.58% |